DelveInsight’s Dup15q Syndrome market report overview of pathophysiology, various diagnostic approaches, and treatment algorithm, including detailed chapters for marketed products and emerging therapies.
DelveInsight’s ” Dup15q Syndrome Market Insights” report delivers an in-depth understanding of the Erectile Dysfunction, historical & forecasted epidemiology, as well as the Dup15q Syndrome market trends in the 7MM (the United States EU5 (Germany, Spain, Italy, France, and United Kingdom) & Japan) for the study period 2018-30.
Some of the key highlights from the Dup15q Syndrome market insights
- As per DelveInsight analysts, the total prevalent population of Dup15q syndrome in the 7MM was 46,259 in 2020.
- The estimates show the highest Dup15q syndrome prevalence in the United States.
- As per the analysis, it is observed that Japan has the second-highest prevalent population of Dup15q syndrome, among 7MM. As per estimates, Japan accounts for approximately 18.35% of the total general cases in 7MM.
- Major players such as Ovid Therapeutics and Takeda and others are involved in developing therapies for the treatment and management of Dup15 Syndrome. These therapies are currently in different stages of clinical development.
- Key pipeline therapies in the Dup15q Syndrome market include Soticlestat (OV935/TAK-935) and many others.
Request for sample for deep insights into Dup15q Syndrome Market @ Dup15q Syndrome Market Report
Dup15q Syndrome Overview
Dup15q syndrome is a neurogenetic disorder that results from duplications of chromosome 15q11.2-13.1. It is characterized by hypotonia, developmental delay and intellectual disability (ID), epilepsy, and autism spectrum disorder (ASD). Dup15q syndrome is categorized into isodicentric 15 chromosomes and interstitial duplication 15 based on the mechanism of duplication.
However, the severity of developmental disabilities can vary widely depending on the type of duplication that occurred and whether it was derived maternally or paternally.
Dup15q Syndrome Epidemiology Segmentation in the 7MM for the Study period 2018-30
- Total Prevalent Cases of Dup15q Syndrome
- Total Diagnosed Prevalence of Dup15q Syndrome
- Type-specific Diagnosed Prevalence of Dup15q Syndrome
Visit here for more information @ Dup15q Syndrome Epidemiology Segmentation
The market is expected to grow due to the factors like an increase in the patient pool, expected entry of emerging therapies, i.e., Soticlestat (OV935/TAK-935), and a deeper penetration of the key pharma companies in the 7MM markets.
Dup15q Syndrome Pipeline Therapy
- Soticlestat (OV935/TAK-935)
Dup15q Syndrome Pipeline Therapy and Key Player
- Ovid Therapeutics/Takeda
Dup15q Syndrome Market Report Key Strengths
- 10 Years Forecast
- 7MM Coverage
- Dup15q Syndrome Epidemiology Segmentation
- Key Cross Competition
- Highly Analyzed Market
- Drugs Uptake
Dup15q Syndrome Key Questions Answered in the report
- What was the Dup15q syndrome market share distribution in 2017, and how it would look in 2030?
- What would be the Dup15q syndrome market size and market size by therapies across the 7MM during the forecast period (2020–2030)?
- What are the key findings of the market across the 7MM, and which country will have the largest Dup15q syndrome market size during the forecast period (2020–2030)?
- At what CAGR, the Dup15q syndrome market is expected to grow at the 7MM level during the forecast period (2020–2030)?
- What would be the Dup15q syndrome market outlook across the 7MM during the forecast period (2020–2030)?
- What would be the Dup15q syndrome market growth till 2030, and what will be the resultant market size in the year 2030?
- How would the market drivers, barriers and future opportunities affect the market dynamics and subsequent analysis of the associated trends?
Please speak to our expert here @ Dup15q Syndrome Market Report
Table of content
| 1 | Key Insights |
| 2 | Executive Summary of Dup15q Syndrome |
| 3 | Dup15q Syndrome Market Overview at a Glance |
| 4 | Disease Background and Overview: Dup15q Syndrome |
| 5 | Case Reports |
| 6 | Epidemiology and Patient Population |
| 7 | United States Epidemiology |
| 8 | EU5 Epidemiology |
| 9 | Japan Epidemiology |
| 10 | Current Treatment and Medical Practices |
| 11 | Unmet needs |
| 12 | Emerging Drugs |
| 13 | Dup15q Syndrome: 7MM Market Analysis |
| 14 | Key Market Assumptions |
| 15 | Seven Major Market Outlook |
| 16 | United States |
| 17 | EU-5 Countries |
| 18 | Japan |
| 19 | Market Drivers |
| 20 | Market Drivers |
| 21 | SWOT Analysis |
| 22 | Appendix |
| 23 | DelveInsight Capabilities |
| 24 | Disclaimer |
| 25 | About DelveInsight |
Get to know about report @ Dup15q Syndrome Market Outlook
Related Reports
Dup15q Syndrome Epidemiology Forecast 2030
DelveInsight’s Dup15q Syndrome- Market Insights, Epidemiology and Market Forecast – 2030 report provides an in-depth understanding of history.
DUPILUMAB Emerging Insight and Market Forecast 2030
DUPILUMAB Drug Insight and Market Forecast- 2030 report by DelveInsight outlays comprehensive insights of the product indicated to treat its approved condition.
Visit our blog
About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences providing comprehensive end-to-end solutions to improve performance.
Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve
For more insights into Pharma industry, Visit Pharma, Healthcare and Biotech Blog